Yuwell Collaboration Will Open Chinese Respiratory Market

AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Published
01 Apr 25
Updated
24 Jul 25
AnalystConsensusTarget's Fair Value
US$11.67
49.7% undervalued intrinsic discount
24 Jul
US$5.87
Loading
1Y
-49.7%
7D
-7.0%

Author's Valuation

US$11.7

49.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 38%

Shared on24 Apr 25
Fair value Decreased 14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 16%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 18%